Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Idexx Laboratories Inc. | 12 | 0 | 2 | 0 | €476.30 | €550.70 | 15.621% |
| Eli Lilly Corp. | 49 | 0 | 6 | 0 | €744.00 | €776.16 | 4.323% |
| Esperion Therapeutis.Inc. | 15 | 0 | 3 | 0 | €1.96 | €8.55 | 336.217% |
| Eledon Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €2.60 | €12.18 | 368.400% |
| VBI Vaccines Inc. | 1 | 0 | 0 | 0 | €0.58 | €3.00 | 414.580% |
| Adverum Biotechnologies Inc. | 7 | 0 | 3 | 0 | €1.38 | €5.60 | 305.913% |
| R1 RCM Inc. | 19 | 0 | 0 | 0 | €11.10 | €17.21 | 55.068% |
| Biolife Solutions Inc | 1 | 0 | 1 | 0 | €19.30 | - | - |
| Pro-Dex Inc. | 15 | 0 | 0 | 0 | €17.30 | - | - |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €69.34 | €100.00 | 44.217% |
| Rhythm Pharmaceuticals | 15 | 0 | 2 | 0 | €34.00 | €45.98 | 35.235% |
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €14.75 | €24.13 | 63.670% |
| Verastem Inc. | 11 | 0 | 2 | 0 | €3.76 | €24.63 | 555.181% |
| Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €1.80 | €4.16 | 131.178% |
| Abbott Laboratories | 17 | 0 | 1 | 0 | €95.81 | €116.71 | 21.817% |
| Cigna Corp. | 16 | 0 | 2 | 0 | €306.55 | €342.35 | 11.679% |
| Dynavax Technologies Corp | 2 | 0 | 1 | 0 | €10.96 | €26.95 | 145.891% |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | €40.40 | €47.17 | 16.757% |
| Brookdale Sr Lvg | 2 | 0 | 0 | 0 | €6.20 | €8.27 | 33.432% |
| Insulet Corp. | 16 | 0 | 2 | 0 | €166.05 | €215.54 | 29.803% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 1 | 0 | €31.40 | €38.99 | 24.168% |
| Intra-Cellular Therapies Inc. | 25 | 0 | 2 | 0 | €60.50 | €79.55 | 31.495% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.50 | - | - |
| Kura Oncology Inc | 1 | 0 | 0 | 0 | €19.63 | €20.00 | 1.885% |